We’re developing a safe, affordable, and immunogenic phage-based vaccine targeting Salmonella Typhi, non-typhoidal Salmonella, and other diarrheal pathogens.
🔗 Support us: experiment.com/projects/developing-a-phage-based-multi-serotype-vaccine-to-combat-typhoid-in-nigeria
experiment.com
Developing a Phage-Based Multi-Serotype Vaccine to Combat Typhoid in Nigeria
Typhoid fever kills over 190,000 annually, with rising multi-drug-resistant (MDR) Salmonella strains worsening the crisis. Current vaccines lose effectiveness within 3–5 years, especially in children....
